Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Flowmail
435
Flowmail
Flowmail is the easiest way to create beautiful mobile-first newsletters. Sign up today on our site
Suggest edits
Founded
2013
Follow us
Also headquartered in Vancouver
Hootsuite
Lululemon
The Next Big Thing
Sierra Wireless
Trulioo
TELUS
Dapper Labs
Bench
Koho
UBC
Alexa global traffic share
Twitter followers
Overview
Add info
Team Size
2
Employees
I work here
Location
Vancouver
,
Canada
Headquarters
Explore Vancouver
Pulse 2.0
Editas Medicine (EDIT) Stock Price: Why It Increased 7.77% Today
Pulse 2.0
Editas Medicine Stock (EDIT): Why The Price Fell Today
Pulse 2.0
Editas Medicine Stock (EDIT): Why The Price Jumped Today
Xconomy
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic
$50,000,000
Venture capital (Series A)
FinSMEs
Rome Therapeutics Raises $50M in Series A Financing
$52,000,000
Venture capital (Series A)
FinSMEs
SwanBio Therapeutics Raises $52M in Series A
$60,000,000
Venture capital (Series A)
FinSMEs
Affinia Therapeutics Raises $60M in Series A Financing
$105,000,000
Venture capital (Series B)
FinSMEs
Akouos Raises $105M in Series B Financing
$105,000,000
Venture capital (Series B)
Pulse 2.0
Precision Genetic Medicine Company Akouos Secures $105 Million In Funding
the home of AI info
Comparing of Minerva Neurosciences Inc. (NERV) and Magenta Therapeutics Inc. (NASDAQ:MGTA)
MedCity News
Editas Medicine CEO steps down as company moves into product development stage
FinSMEs
Alexion To Acquire Syntimmune, for Up To $1.2 Billion
Health
$50,000,000
Venture capital (Series A)
FinSMEs
Precision Genetic Medicine Company Akouos Raises $50M in Series A
Science
Funding
Health
$100,000,000
IPO
PE HUB
Magenta Therapeutics starts trading on the NASDAQ
Stock markets
Health
$52,000,000
Venture capital (Series C)
Venture Funding News
,
PE HUB
Magenta Therapeutics Secures $52M in Series C
FinSMEs
Magenta Therapeutics Secures $52M in Series C Financing
Funding
Health
PE HUB
| Apple Tree-backed Syntimmune appoints president and CEO
Strategy
Health
PE HUB
VC-backed Spero Therapeutics sets IPO pricing terms
Stock markets
Funding
PE HUB
VC-backed Spero Therapeutics files for IPO
Stock markets
Health
Funding
$20,000,000
Venture capital (Series D)
prnewswire
Sebacia Announces $36 Million Equity and Debt Financing to Advance Breakthrough In-Office Procedure for Acne
